fulvestrant has been researched along with zearalenone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehme, K; Mueller, SO; Simon, S | 1 |
| Benahmed, M; Inoubli, L; Koraïchi, F; Lakhdari, N; Lecoeur, S; Mauduit, C; Meunier, L; Prouillac, C; Vega, A | 1 |
2 other study(ies) available for fulvestrant and zearalenone
| Article | Year |
|---|---|
Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.
Topics: Benzhydryl Compounds; Cell Line, Tumor; Cluster Analysis; DDT; Diethylstilbestrol; Endocrine Disruptors; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genistein; Humans; Oligonucleotide Array Sequence Analysis; Phenols; Phytoestrogens; Polymerase Chain Reaction; Receptors, Estrogen; Reproducibility of Results; Resveratrol; Risk Assessment; RNA, Messenger; Stilbenes; Time Factors; Zearalenone | 2009 |
Neonatal exposure to zearalenone induces long term modulation of ABC transporter expression in testis.
Topics: Aging; Animals; Animals, Newborn; ATP-Binding Cassette Transporters; Blotting, Western; Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Fulvestrant; Immunohistochemistry; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sertoli Cells; Testis; Zearalenone | 2013 |